Boundless Bio financials
$2.56−1.92%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$24.4M | -$14.5M | -$14.0M | -$15.1M | -$17.1M | -$17.3M | -$18.3M | -$18.7M | -$19.4M | -$16.9M |
| Net income | -$23.7M | -$13.6M | -$12.9M | -$13.9M | -$15.7M | -$15.8M | -$16.4M | -$16.5M | -$17.0M | -$15.4M |
| Net margin | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-1.06 | $-0.60 | $-0.58 | $-0.62 | $-0.70 | $-0.71 | $-0.73 | $-0.74 | $-0.77 | $-12.27 |
| EBITDA | -$23.1M | -$14.2M | -$13.7M | -$14.8M | -$16.7M | -$17.0M | -$18.0M | -$18.5M | -$19.1M | -$16.6M |
| Operating cash flow | -$21.0M | -$15.0M | -$10.1M | -$10.2M | -$11.8M | -$14.5M | -$15.6M | -$13.3M | -$16.2M | -$15.8M |
| Free cash flow | -$21.0M | -$15.0M | -$10.5M | -$10.2M | -$11.9M | -$14.6M | -$16.0M | -$13.7M | -$17.7M | -$15.9M |
| Diluted shares | 22.5M | 22.4M | 22.4M | 22.4M | 22.4M | 22.3M | 22.4M | 22.3M | 22.0M | 1.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.2M | $17.5M | $17.9M | $15.0M | $14.7M | $15.1M |
| Short-term investments | $52.4M | $75.4M | $89.7M | $102.6M | $112.5M | $123.1M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $73.7M | $141.0M | $157.1M | $168.7M | $179.5M | $191.2M |
| Total liabilities | $7.8M | $54.6M | $58.4M | $58.6M | $56.8M | $54.6M |
| Shareholders' equity | $66.0M | $86.4M | $98.7M | $110.2M | $122.7M | $136.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology